Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
2026/02/19 Introduced, Referred to Assembly Health Committee
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | NJ A4181 | 0 | 13.78 | 19-02-2026 |
| 2 | NJ A4190 | 0 | 14.76 | 19-02-2026 |
| 3 | NJ A4182 | 0 | 18.14 | 19-02-2026 |
| 4 | NJ A4178 | 0 | 12.49 | 19-02-2026 |
| 5 | NJ A4179 | 0 | 14.63 | 19-02-2026 |
| 6 | NJ A4185 | 0 | 11.88 | 19-02-2026 |
| 7 | NJ A4188 | 0 | 12.74 | 19-02-2026 |
| 8 | NJ A4694 | 0 | 13.7 | 16-03-2026 |
| 9 | NJ A4748 | 0 | 11.1 | 19-03-2026 |
| 10 | NJ A5487 | 0 | 12.91 | 14-09-2026 |